AllgenL. G.: Laboratory experience of lithium toxicity in man.Acta Psychiat. Scand. Suppl.207: 98, 1969.
2.
AmdisenA. and SjögrenJ.: Lithium absorption from sustained-release tablets.Acta Pharm. Suec. (Sweden)5: 465, 1968.
3.
BrownW. T.: The use of lithium carbonate in the treatment of mood disorders.Can. Med. Assoc. J.108: 742, 1973.
4.
CadeJ. F. J.: Lithium salts in the treatment of psychotic excitement.Med. J. Aust.2: 349, 1949.
5.
CoatsD. A., TrautnerE. M., and GershonS.: Treatment of lithium poisoning.Austr. Ann. Med.6: 11, 1957.
6.
DemersR. and HeningerG.: Pretibial edema and sodium retention during lithium carbonate treatment.J.A.M.A.214: 1845, 1970.
7.
DousaT. and HechterO.: The effect of NaCL and LiCL on vasopressin-sensitive adenyl cyclase.Life Sci. (I)9: 765, 1970.
8.
FloruL.: Klinische Behandlungsversuche des lithiumbedingten Tremors durch einen B-Rezeptorenantagonisten (Propranolol). Clinical Attempts of Treating Lithiuminduced Tremor by Administration of βeta-Receptor Blockers (Propranolol).Int. Pharmacopsychiatry6: 197, 1971.
9.
GershonS. and ShopsinB.: Lithium — Its Role in Psychiatric Research and Treatment.New York, Plenum Press,1973.
10.
GershonS. and ShopsinB.: Pharmacology — Toxicology of the Lithium Ion. In: Lithium — Its Role in Psychiatric Research and Treatment, p. 109, New York, Plenum Press, 1973.
11.
HarrisC. A. and JennerF. A.: The inhibition of the action of vasopressin by lithium ions.J. Physiol. (London200: 59, 1969.
12.
HarrisC. A. and JennerF. A.: The ionic specificity of lithium as an inhibitor of the action of vasopressin.J. Physiol. (London)203: 73, 1969.
13.
KirkL., BaastrupP. C. and SchouM.: Propranolol and lithium-induced tremor.Lancet1: 839, 1972.
14.
KirkL., BaastrupP. C. and SchouM.: Letter: Propranolol treatment of lithium-induced tremor.Lancet2: 1086, 1973.
15.
LehmannH. E. and BanT. A.: “Early Clinical Drug Evaluation Unit.” Report from Douglas Hospital. E.C.D.U.E. Meeting. Washington, D.C., 1969.
16.
MurphyD. L., GoodwinF. K. and BunneyW. E.Jr.: Leukocytosis during lithium treatment.Am. J. Psychiatry127: 1559, 1971.
17.
RadomskiJ. L., FuyatH. N., NelsonA. A. and SmithP. K.: The toxic effects, excretion and distribution of lithium chloride.J. Pharmacol.100: 429, 1950.
18.
RifkinA., KleinD. F. and QuitkinF.: Organic brain syndrome during lithium carbonate treatment.Compr. Psychiatry14: 251, 1973.
19.
SchouM.: Recent Advances in the Treatment and Prevention of Lithium-induced Side Effects and Lithium Intoxication. Presented at Symposium on “Advances in the Drug Therapy of Mental Illness”. Geneva, 1973.
20.
SchouM., AmdisenA., JensenS. E. and OlsenT.: Occurrence of goitre during lithium treatment.Br. Med. J.3: 710, 1968.
21.
SchouM., AmdisenA. and Trap-JensenJ.: Lithium poisoning.Am. J. Psychiatry125: 520, 1968.
22.
ShopsinB., FriedmannR. and GershonS.: Lithium and leukocytosis.Clin. Pharmacol. Ther.12: 923, 1971.
23.
ShopsinB., JohnsonG. and GershonS.: Neurotoxicity with lithium: Differential drug responsiveness.Int. Pharmacopsychiatry5: 170, 1970.